Fed. Circ. In September: The Printed Matter Doctrine Expands

This article is part of a聽monthly column聽that highlights an important patent appeal from the previous month. In this installment, we examine the Federal Circuit's ruling in聽Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals...

Already a subscriber? Click here to view full article